Cargando…
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613870/ https://www.ncbi.nlm.nih.gov/pubmed/31338223 http://dx.doi.org/10.1136/svn-2018-000163corr1 |
Ejemplares similares
-
Intravenous tirofiban therapy for patients with capsular warning syndrome
por: Li, Wei, et al.
Publicado: (2019) -
Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
por: Liu, Yunzhu, et al.
Publicado: (2022) -
Correction to: Comparison of Safety and Efficacy after Emergency Stenting in Patients Exhibiting Intracranial Atherosclerotic Stenosis Associated with Large-vessel Occlusion with and without Intravenous Infusion of Tirofiban
por: Garayzade, Rana, et al.
Publicado: (2023) -
Capsular warning syndrome: clinical analysis and treatment
por: He, Lanying, et al.
Publicado: (2019) -
Correction: Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion
por: Pan, Xiding, et al.
Publicado: (2022)